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ABSTRACT
Nijmegen breakage syndrome (NBS) is a rare autosomal receSSIve chromosome-
instability syndrome characterized by microcephaly, growth retardation, immuno-
deficiency, and cancer predisposition, with cellular features similar to that of ataxia
telangiectasia (AT). NBS results from mutations in the mammalian gene Nbs] that codes
for a 95-kDa protein called nibrin, NBSI, or p95. To establish an animal model for NBS,
we attempted to generate NBS I knockout mice. However, NBS I gene knockouts were
lethal at an early embryonic stage. NBSI homozygous(-I-) blastocyst cells cultured in
vitro showed retarded growth and subsequently underwent growth arrest within 5 days of
culture. Apoptosis, assayed by TUNEL staining, was observed in NBSI homozygous(-I-)
blastocyst cells cultured for four days. NBSI heterozygous(+I-) mice were normal, and
exhibited no specific phenotype for at least one year. However, fibroblast cells from
NBSI heterozygous(+I-) mice displayed an enhanced frequency of spontaneous
transformation to anchorage-independent growth as compared to NBSI wild-type(+I+)
cells. Furthermore, heterozygous(+I-) mice exhibited a high incidence of hepatocellular
carcinoma after one year compared to wild-type mice, even though no significant
differences in the incidence of other tumors such as lung adenocarcinoma and lymphoma
were observed. Taken together, these results strongly suggest that NBSI heterozygosity
and reduced NBS I expression induces formation of specific tumors in mice.
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INTRODUCTION
Nijmegen breakage syndrome (NBS) is a rare autosomal recessive chromosome-
instability syndrome characterized by microcephaly, growth retardation,
immunodeficiency, and cancer predisposition(5, 9, 32). NBS was originally believed to
be a variant form of ataxia telangiectasia (AT) because the characteristic features of NBS
are very similar to that of AT. However, some of the characteristic features of AT such
as ataxia, cerebellar degeneration and ocular telangiectasia are not seen in NBS patients,
while the characteristic bird-like face accompanied by microcephaly are specific to
NBS(5). Cancer incidence observed in NBS patients is higher than in AT, the risk for
malignancy in NBS patients being as high as 34%(9). The prominent cancers observed in
NBS patients are lymphoreticular malignancies such as Band T cell lymphomas,
rhabdomyosarcoma, haemoblastoma, and neuroblastoma(32).
Cells from NBS patients show hypersensitivity to IOnIZmg radiation (IR),
chromosome instability, and radioresistant DNA synthesis (RDS)(9, 27, 32). These
cellular features are similar to that of AT. Complementation analysis can distinguish one
cell type from another, while AT and NBS can be distinguished by clinical criteria. This
suggests that the corresponding gene products function in the same pathway in response
to DNA double-strand breaks (DSBs) which are typically generated by ionizing
radiation( 13).
The gene mutated in NBS was cloned by three different groups employing
positional cloning within a critical region of chromosome 8q2l (23, 34) or by
identification of the gene encoding a 95-kDa protein that was part of the Mrell-Rad50
DSB repair complex(6). This novel mammalian gene Nbs} codes for a 95-kDa protein
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called nibrin, NBSl, or p95. NBSI is part of the Mrel1/Rad50 complex that associates
with DNA DSBs in irradiated cells early in the cellular DNA-damage response,
indicating that it may function in the early stages of detection and signaling of DNA
damage. Due to the similarity of AT and NBS cellular phenotypes, it has been
hypothesized that NBS and ATM act in a common DNA-damage response pathway.
Indeed, ATM kinase has been shown to phosphorylate NBSI in response to IR-induced
DNA damage. This phosphorylation event is required for activation of an S-phase
checkpoint(l2, 18,37,40).
The Mrell/Rad50/NBSl complex is believed to be a sensor of abnormal DNA
structures and/or a regulator of the postreplication repair process. This complex is part of
a large multi-subunit protein complex called BASC, for BRCAl-associated genome
surveillance complex, consisting of various repair proteins including ATM, BLM, MSH2,
MSH6, MLHl, and RFCl-RFC2-RFC4 complex(26, 35). Furthermore, the
Mrell/Rad50/NBSl complex is associated with telomeric repeat-binding factor TRF2,
suggesting additional functions at the telomere, possibly involving modulation of t-Ioop
formation(42). Mrell and Rad50 form discrete nuclear foci in cells treated with DSB-
inducing agents. NBS 1 deficiency in cells from NBS patients completely abrogates the
formation of Mrel1/Rad50 IR-induced foci(6). The abrogation of Mrel1/Rad50/NBSl
protein complex in NBS cells indicates an important role for NBSI in linking DSB repair
and cell cycle checkpoint functions(26).
In order to establish an animal model for NBS, we performed gene targeting
experiments to generate NBS I-null knockout mice. However, NBS 1 gene knockouts
were embryonic lethal at an early stage. Here we report the embryonic lethality of
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homozygous NBS I-null knockout embryos and characterize the potential oncogemc
phenotype ofNBS I heterozygous mice.
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MATERIALS AND METHODS
Construction of the targeting vector
A genomic clone ofNBS 1 locus was isolated from l29/Sv mouse genomic library
using two EST clones (IMAGE consortium clone ID: 567467 and 974211) of mouse
NBSI gene. Following restriction mapping and determination ofintron-exon boundaries,
restriction fragments were subcloned into pBluescriptlISK(+) (Stratagene). Targeting
vector was constructed using a PstI-AgeI 5.5kb fragment containing exon 2 to 5 and a
PstI-NarI 1.2kb promoter fragment, which were inserted into pBluescriptlISK(+) vector
flanking either side of a PGK-neo cassette.
Targeting of ES cells and generation of germ-line chimeras
Transfection of the linealized targeting vector to cn ES cells was performed by
electroporation, and colonies surviving G4l8 (200j.tg/ml) selection were screened by
PCR and Southern blotting of EcoRI-digested genomic DNA. A 1.5kb PstI fragment 5'
upstream of the promoter sequence was used as a probe. Correctly targeted ES clones
were then injected into C57BL/6 blastocysts followed by transfer to a pseudopregnant
foster mother to generate chimeric mice. The chimeras were crossed with C57BL/6
females, and germ-line transmission was demonstrated by the presence of agouti coat
color in the Fl offspring. The presence of a disrupted NBSI allele was confirmed by
Southern blot analysis. NBS 1 heterozygous mice were maintained by intercrossing. This
study was conducted in compliance with all relevant federal guidelines and institutional
policies on murine research.
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Genotyping of NBSl knockout mice
The genotype of individual mice was detennined by PCR, which distinguishes
between the endogenous and targeted NBS I alleles. PCR was perfonned in a 20 f.ll
reaction with 100ng of genomic DNA, Ix PCR buffer (Perkin-Elmer, 1.5mM MgClz), 0.5
f.lM(each) of primers: NB-27: 5'-TTC ATT GAT TAA AGC GTC CAG TT-3', NB-32:
5'-CAC TCA GGA TAC AGT GGA AAA GAT-3', NB-35: 5'-GAC GTG CGC GTT
CCC AGG ACT CTG-3', Pol-8: 5'-GCA GCC TCT GTT CCA CAT ACA CTT-3',
O.2mM (each) of dNTPs, and 0.8U of AmpliTaq DNA polymerase. Primers NB-32 and
NB-35 give a product of wild-type allele that is 335bp; primers NB-27 and Pol-8 yield a
product of the targeted allele that is 161bp.
The genotype of blastocysts and early stage embryos was detennined by nested
PCR. The PCR conditions used are the same as described above. Initial PCR was
perfonned using mixed primers, NB-28: 5'-TTA AGG GAA ATT GGG ACT ACT TG-
3', NB-36: 5'-GAA AGA ACT CCC CGC CGC CTC CTT-3', Pol-7: 5'-TGA GGG
GAT CCG CTG TAA GTC TGC-3'. The secondary primers for the wild-type allele are
NB-32 and NB-35, which generate a 335bp product as mentioned above and primers for
the targeted allele are NB-32 and Pol-8, which gives a 331 bp product. After separation
of PCR products by electrophoresis, amplified DNA was transferred to Hybond N+
membrane and visualized by hybridization with 3zP_end labeled primer probes which
specifically detect the wild-type (NB-34: 5'-ACT CTG ACA AGT TCT TCG GAA
AGG-3' ) or the targeted allele (NB-27).
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Establishment of primary ear fibroblasts
Primary ear fibroblast cells were isolated from 4-week-old NBSI wild-type(+I+)
and heterozygous(+I-) sibling mice. Cells were maintained at 37°C in alpha-MEM
medium supplemented with 10% fetal calf serum, 100 Vlml penicillin and 100 /-Lg/ml
streptomycin in a humidified atmosphere with 5% C02.
Blastocyst culture and TUNEL assay
e3.5 blastocysts were collected from NBSI heterozygous(+I-) intercrosses, and
rinsed in Dulbecco's modified Mg/Ca free phosphate buffered saline (Gibco BRL).
Blastocysts were cultured in 4-well chamber slides in 1 ml of Dulbecco's modified
Eagles medium (Gibco BRL) supplemented with 2mM L-glutamine, Ix non-essential
amino acids, 1,000Vlmlleukemia inhibitory factor (LlF), 100 Vlml penicillin, 100 /-Lg/ml
streptomycin, O.lmM beta mercaptoethanol, and 20% fetal calf serum. Blastocysts were
fixed in 4% paraformaldehyde after 1-3 days in culture. Permealization and TUNEL
assay were performed using the Apoalert DNA fragmentation assay (Clontech) according
to manufacturer's instructions with the following modification: a hydrophobic ring was
drawn around the blastocyst and the assay was performed using micro-volumes of the
sample. Samples were also stained with DAPI or PI. Images were taken at 200x and
400x magnification and captured using the Spot Diagnostic Imaging System
(model: 1.0.0) (Diagnostic Instrument Inc.) with Olympus BX60 microscope.
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Colony formation assay in soft agar
The ability of primary ear fibroblasts to grow III soft agar under anchorage-
independent conditions was determined by use of a modified MacPherson method(21).
Plastic petri dishes (60mm) were coated with a layer of 5ml of 0.5% agarose (Sigma
Type I) in regular medium. Two ml of the cell suspension was mixed with 4ml of the
0.5% agarose solution, and 1.5ml of the resulting cell suspension was spread over the
basal agarose layer. Subsequently, the cultures were fed once a week by adding 1ml of
complete medium (without agarose). Size of the colonies in soft agar was determined at 2
days and 1 month after seeding by taking photomicrographs of the cultures on an inverted
microscope. The circumferences of 100 random colonies for each experimental point
were traced, the diameters measured, and the volume determined for each soft agar
colony.
Histological analysis of NBS1 embryos and tumors derived from heterozygous(+/-)
mice
Whole embryos were observed and photographed under a dissecting microscope
or a low power microscope. Embryonic stage was estimated using timed mating. Whole
embryo sacs taken at e6.5 were fixed using 4% paraformaldehyde, sectioned for histo-
pathological analysis, and stained by hematoxylin and eosin method.
For the tumor histopathological analysis from aging mice, tissues exhibiting
pathological changes when inspected visually at autopsy were frozen at first in liquid
nitrogen and then fixed in 10% formalin solution. Sectioned specimens were stained by
hematoxylin and eosin method and analyzed for pathological diagnosis.
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RESULTS
Generation of NBSl gene knockout mouse
The targeting vector for NBSI gene was constructed by substituting the NBSI
promoter region (about 200bp upstream of ATG start codon), entire exonl, and 2kb of
intronl with a PGK-neo cassette (Fig.1A). This substitution removed the transcription
and translation initiation sites resulting in null expression of mouse NBS 1 gene.
The linearized targeting vector was transfected into cn ES cells. A single
targeted ES allele was observed in 5 out of 400 isolated G4l8 resistant ES cell colonies
(Fig.1B, C). Three targeted ES clones were injected into C57BL/6 blastocysts to generate
chimeric mice. Only one of the three ES clones showed good contribution towards
chimera formation as assayed by analysis of coat color. These chimeras were crossed
with C57BL/6 females to generate Fl progenitors. Among the 17 Fl mice that were
obtained, 7 males and 5 females showed successful transmission of the targeted allele as
assayed by PCR and Southern blot analysis. The F2 and F3 NBS heterozygous(+/-) mice
were mated to generate NBSI homozygous(-/-) embryos and blastocysts. Fl and F2 mice
were maintained and observed for tumor progression.
Embryonic lethality of NBSI-null homozygous(-I-) mice
Upon intercrossing NBSI heterozygous mice (+1- x +1-), we were unable to obtain
any NBSI homozygous(-I-) mice from the resulting 108 progeny (Tablel). Genotype
analysis of these viable mice revealed that 39 mice were wild-type(+I+) and 69 mice
were heterozygous(+/-), a ratio of 1: 1.8. This strongly suggests that the NBS 1
homozygous(-I-) genotype is embryonic lethal, and that NBSI is essential for embryonic
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development. To detennine the embryonic stage at which nonnal development of the
NBSl-null embryo was arrested, e8.5 to e13.5 embryos were isolated and analyzed by
time-mated heterozygous(+I-) intercrossing (Fig.2). Compared to e13.5 heterozygous(+I-
) and wild-type(+I+) embryos, we observed extremely small resorbed homozygous(-I-)
embryos within tiny extra-embryonic tissues (placenta, decidua, yolk sac). These
homozygous(-I-) embryos were non-structural and consisted of an organized mass of
resorbed tissues. At earlier embryonic stages, e8.5 to elO.5, the size differences between
the heterozygous(+I-) and homozygous(-I-) embryos were not so remarkable, and we
observed fine structures within homozygous(-I-) embryos. However, homozygous(-I-)
embryos were still small compared to heterozygous(+I-) or wild-type(+I+) embryos.
To further confinn the abnonnal embryonic development of homozygous(-I-)
embryos, we perfonned histological analysis of e6.5 embryos by sectioning whole
deciduas (Fig.3). The size of abnonnal embryos was slightly smaller compared to nonnal
embryos, and the number of cells in the abnonnal embryos was reduced and tubular
structures were disrupted. This suggests that resorbtion of abnonnal embryos starts just
before the gastrulation period.
The genotypes of embryos obtained from heterozygous(+I-) intercrosses were
identified by nested PCR using the core tissues derived from resorbed embryos and tail
tissues of embryos with nonnal appearance (FigA, Table 1). PCR results using DNA
from nonnal embryos showed wild-type or heterozygous genotypes. On the other hand,
resorbed embryos exhibited homozygous(-1-) genotype.
When we obtained e3.5 blastocysts from heterozygous intercrosses, no obvious
structural abnonnalities were observed. Genotyping analysis of a total of 135 blastocysts
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revealed a genetic ratio similar to that expected to arise from Mendelian inheritance,
suggesting that NBS 1 deficiency does not affect blastocyst development (Table 1). Taken
together, these results reveal that development of NBS 1 homozygous (-1-) embryos is
arrested at an embryonic stage as early as e4.5 to e5.5.
To further analyze the functional importance of NBSI gene in mouse cells, we
attempted to establish cell lines from NBS 1 homozygous(-I-) embryonic tissues.
Although we sometimes observed a few attached embryonic fibroblast cells around e7.5
and e8.5 embryo tissues, these cells failed to grow and disappeared within a few days.
We also attempted to culture the blastocyst cells on feeder cells to establish NBS 1 null
ES cells (Fig.5). The wild-type(+I+) and heterozygous(+I-) cells from blastocyst inner
cell mass (lCM) kept growing under these in vitro culture conditions and were
established as ES cells after several passages. On the other hand, cells derived from
NBSI homozygous(-I-) blastocyst ICM stopped growing after 5 days in vitro, and then
disappeared. After 7 days in culture, only giant trophoblast cells remained, and replaced
the feeder cells.
To verify the manner by which cell death occurred in cells derived from NBSI
homozygous blastocysts within 7 days, blastocyst cells cultured in vitro were analyzed by
TUNEL assay to detect apoptosis (Fig.6). The e3.5 blastocysts isolated after
heterozygous intercrossing were cultured in DMEM medium. Blastocysts were fixed on
the 24th and 72nd hour of culture. At the 24th hour, most of the blastocysts had not yet
hatched from the zona pelucida, and contained only a few TUNEL positive cells within
the ICM from homozygous(-I-), heterozygous(+I-) and wild-type(+I+) blastocysts. After
3 days in culture, the blastocysts were hatched from the zona pelucida and three-
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dimentional expansion of ICM cells was observed. A large number of TUNEL positive
cells within ICM-derived cells were observed in homozygous blastocysts. On the other
hand, TUNEL positive cells were still low in number for wild-type(+/+) and
heterozygous(+/-) cells. This suggests that NBS 1 is essential for early embryonic
development and in vitro growth of cells derived from blastocysts, and that NBS 1
deficiency causes extensive apoptotic cell death in growing ICM cells.
Tumor progression in NBSl heterozygous (+/-) mice
It has been observed that ATM and ATR (ATM/Rad3-related kinase)
heterozygous mice have a high incidence of tumor formation(1, 3,4). In case of humans,
it has also been reported that NBS heterozygous individuals showed an increased
incidence of tumor formation(28). To verify the phenotypic effect of heterozygosity(+/-)
with respect to tumor incidence and progression, we first measured the ability of ear
fibroblasts derived from NBS 1 heterozygous(+/-) mice to undergo spontaneous
transformation to anchorage-independent growth (Fig.?). Cells derived from wild-
type(+/+) or heterozygous(+/-) mice were plated in soft agar and their ability to form
colonies was measured after 4 weeks in culture. Most of the cells (90%) derived from
wild-type(+/+) mice could not form colonies, stopped growing, and remained as single
cells. There was no colony observed whose diameter was over 50 /-lm. On the other hand,
a significant percentage of cells derived from heterozygous mice predominantly formed
colonies (54%) as opposed to remaining as single cells (46%). Furthermore, 15% of
cells formed colonies larger than 50 /-lm in diameter. NBS1 heterozygous(+/-) cells
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exhibited anchorage-independent growth in soft agar, suggesting that NBS 1
heterozygous(+1-) cells readily undergo transformation as compared to wild type cells.
To determine the influence of NBSI heterozygosity(+I-) on tumor formation in
vivo, we examined tumor incidence in heterozygous(+I-) or wild-type(+I+) mice that
were over one year-old (Fig.S; Table2). Fl and F2 sibling mice maintained in the same
cages were selected at a certain point after they were a year old, euthanized, and
autopsied. Internal organs were inspected, and, once pathological abnormalities were
observed, abnormal tissues were further examined by histopathology. Finally, a
pathological diagnosis was made. Three types of tumors: lung adenocarcinoma(p=0.41)
and lymphoma(p=0.59) from thymus, spleen or lymphnodes were commonly observed in
both wild-type(+I+) and heterozygous(+I-) NBSI mice. On the other hand hepatocellular
carcinoma (HCC) (p=O.IO) in liver was observed to occur frequently only in
heterozygous mice (p value was obtained by Fisher's exact test). All of HCC were
observed in male mice.
We further analyzed the loss of heterozygosity of tumors obtained from NBSI
heterozygous(+1-) mice. Genomic DNA was extracted from tumors and normal liver
tissues. Southern hybridization was performed using probes detecting the targeted locus
around exon 1. We were unable to detect any loss of heterozygosity (LOH) at the
targeted region (data not shown). This strongly suggests that NBSI gene dosage has an
effect on the incidence of specific tumors such as HCC. However, unlike known tumor
suppressor genes, a total loss of NBS1 gene product is not sufficient to induce tumor
formation since NBS 1 homozygous(-1-) cells die just after a few rounds of cell division.
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DISCUSSION
We carried out targeted disruption of the NBSI gene in mice at the transcription
start site resulting in null expression of the gene. We observed that development of
homozygous(-/-) NBSI knockout embryos was arrested at a very early stage around e6.5
and that their blastocyst cells were not capable of surviving in vitro culture conditions.
Apoptosis was observed in cultured blastocyst cells by TUNEL assay. NBSI
heterozygous(+/-) mice were normal and exhibited no specific phenotype for at least one
year. However, fibroblast cells from NBSI heterozygous(+/-) mice showed enhanced
transformation compared to NBS I wild-type(+/+) cells. After one year, heterozygous
(+/-) mice started developing hepatocellular carcinomas (HCC).
There is a clear phenotypic difference between human NBS patients and our
knockout homozygous(-/-) mouse model. Even though the onset of human NBS is
thought to be at a pre- or early postnatal stage, about 70% of patients do not show any
obvious growth retardation at birth and only exhibit microcephaly in 75% of cases and
sometimes survive for over two decades(32). On the other hand, the homozygous(-/-)
null genotype in mice not only results in early embryonic lethality, but most likely
lethality even at the cellular level because, in spite of intensive efforts, we were unable to
establish homozygous(-/-) cells from blastocysts and early embryos. This correlates very
well with previous findings indicating that null mutations in Mrell and Rad50, which
form a functional complex with NBSI, are lethal in mice(20, 38). Also, another NBSI
gene knockout constructed by deleting the promoter, exon I, and 700bp of intron I showed
a similar lethal phenotype(41). Recently, it was reported that the NBSI gene mutation
observed in 90% of NBS patients (657deI5) causes a hypomorphic defect as an
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alternative mode of translation permits expression of a smaller p70 protein with partial
functions(22). The hypomorphic defect has been proposed to diminish the severity of the
human NBS phenotype and could explain the lack of lethality in humans that is in
contrast to the lethality observed in NBS knockout mice. Also, it was reported very
recently that disruption of exons 2 and 3 of the mouse NBS 1 gene results in viable
mice(l4). This discrepancy with our results is probably because in this case the targeted
allele can still express an N-terminal truncated NBSI that, like in humans, could prevent
embryonic lethality.
It has been reported that AT carriers have a high risk of cancer, especially breast
cancer in women(30). NBS carriers have been shown to have a higher risk of cancer-
predisposition than AT carriers, even though the specific cancers were not identified(28).
In our study, we observed a high degree of transformation of fibroblast cells derived from
NBSI heterozygous(+/-) mice. In vivo, we also observed a high incidence of a specific
tumor, hepatocellular carcinoma (ReC) in heterozygous(+/-) mice. Two other cancers,
lung adenocarcinoma and lymphoma, were also detected, but with a nearly equal
incidence between wild-type(+/+) and heterozygous(+/-) sibling mice. To understand the
mechanism of carcinogenesis observed in NBSI heterozygous(+/-) mice, we analyzed
loss of heterozygosity (LOR) in tumors using a DNA probe complimentary to the
targeted locus of the exonl region. We were unable to observe any LOR, which, taken
together with the potential cellular lethality of NBS 1 homozygous null cells, leads us to
speculate that reduced NBS 1 gene expression in heterozygous liver cells is sufficient to
induce chromosome instability and accelerate cancer progression.
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In the human NBS I carrier population, there are no obvious tendencies towards
liver tumor formation in their cancer spectrum(28). The leading cause ofHCC in humans
is virus infection by agents such as hepatitis Band C virus, while genetic factors that
enhance HCC progression are still unclear(7). In mice, no clear correlation between virus
infection and HCC has been identified. On the other hand, incidence of HCC in male
mice is very high, suggesting a hormonal effect on HCC occurrence. Our cases of HCC
were also observed only in male mice. NBS I gene expression in liver is very high
compared to other tissues as evaluated by northern blot analysis(36). This suggests that
in mice liver cells, NBS I gene expression may be important for maintaining
chromosomal integrity and preventing specific cancer (HCC) progression.
The main function of NBS I protein is still unclear, and it is speculated that NBSI
is involved in both homologous recombination (HR) and non-homologous end-joining
(NHEJ) pathways of DNA double-strand break repair(15, 33). Knockouts of several
genes related to the NHEJ pathway do not show any lethality (Ku70, Ku80 or DNA-
PKcs)(16, 24, 25) or show embryonic lethality only at a late stage(XRCC4, LigaseIV)(IO,
II). Furthermore, null of expression of ATM, which is involved in DNA damage
recognition and signaling to the cell cycle machinery, does not lead to lethality(2, 39).
On the other hand, mice with deletions of HR-related genes show early embryonic
lethality(8, 17, 19, 29, 31), suggesting that HR is essential for early mouse development.
From the embryonic lethality of NBS 1 knockout mice and the lethality of knockouts of
its two interacting proteins, Mrell and Rad50, the main function of NBSI or
Mrell/Rad50/NBSI complex would appear to be related to the HR pathway.
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With the failure to establish a mouse model for human NBS and to obtain viable
NBS 1 deficient cell lines, we are currently constructing a conditional knockout for the
NBSI gene and knockin mice carrying the common mutation (657de15) observed in
human NBS patients. By further studying these mice in detail, it will become clear as to
how loss of the NBS 1 gene may contribute to cancer progression and why NBS 1 IS
essential for early mouse development.
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FIGURE LEGEND
Figure 1 (A) Schematic diagram of mouse NBSl gene locus (exonl to 5) and
Southern hybridization probe A (Top), the targeting construct (Middle) and the targeted
allele (Bottom). E: EcoRI, P: Pst!. (B) PCR analysis of targeted ES cells. Using
primers indicated on the map, a l.3kb DNA fragment was amplified only from
homologously-targeted ES cells (Clone #2, 6, 15, 18 and 22). M: marker, P: positive
control, N: negative control, B: Blank. (C) Southern blot analysis of EcoRI-digested
DNA from targeted ES cells. Targeted ES cells (Clone #2, 6, 15, 18 and 22) show two
signals, one from the wild type allele (llkb) and the other from the targeted allele (5kb).
Figure 2 Normal NBSl heterozygous(+/-) and resorbed NBSl homozygous(-/-)
embryos. Heterozygous(+/-) e13.5 embryo is shown with extraembryonic tissues
(placenta, yolk sac)(A), and embryo only(B). Homozygous(-/-) e13.5 embryo with
extraembryonic tissue(C) is smaller than heterozygous(+/-) embryo. Comparison of a
heterozygous (+/-) and two homozygous(-/-) el0.5 embryos with deciduas are shown in
(D). Embryos isolated from (D) are shown in (E) (+/-), (F) (-/-), and (G)(-/-).
Comparison of heterozygous(+/-) and homozygous(-/-) e8.5 embryo with decidua(H).
Sectioned view of homozygous embry-o with decidua from (H, right) are shown in (I).
Embryo undergoing resorbtion is centrally-located in the top part of the section(I).
Comparison ofheterozygous(+/-) and homozygous(-/-) e8.5 embryos (J).
Figure 3 Histological analysis of e6.5 embryos obtained from heterozygous
intercrossing. Hematoxylin and eosin staining of control normal embryos(A, B) and
- 20-
Kurimasa et al.
abnonnal embryos (C, D). The abnonnal embryo had not developed appreciably beyond
e5.5-e6.0 stage and had started deteriorating. erne: embryonic ectodenn, pc: proamniotic
cavity, exe: extraembryonic ectodenn.
Figure 4 Example of PCR genotyping of cultured blastocysts subsequently
TUNEL stained as described in Table!, Fig.5 and Fig.6 are shown in (A). PCR
genotyping using embryonic tissue (Tablel) is shown in (B). Specifically amplified PCR
products from wild type or knockout alleles were transferred to nitrocellulose membrane
and hybridized with 32p end-labeled internal primers specific for wild-type or knockout
PCR products.
Figure 5 NBSl homozygous(-/-) cells from blastocyst (e3.5) are unable to
proliferate in vitro. The e3.5 blastocysts were isolated from NBSl heterozygous(+/-)
intercrosses and were cultured with feeder cells (MEFs). After 2 days of culture, NBSl
wild-type(+/+), heterozygous(+/-) and homozygous(-/-) blastocysts hatched from the
zona pellucida and implanted onto feeder cells. During the first 3 days of culture, the
inner cell mass(ICM) of NBS 1 homozygous(-/-) blastocysts were indistinguishable from
that ofwild-type(+/+) or heterozygous(+/-) blastocysts. However, while the ICM cells of
wild-type(+/+) and heterozygous(+/-) blastocysts continued to expand, NBSI
homozygous(-/-) ICM cells stopped expanding after 5 days.
Figure 6 Disruption of NBSl leads to apoptotic cell death of early embryonic
cells. TUNEL staining of cultured blastocysts obtained from NBSI heterozygous(+/-)
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intercrosses were performed after 24 hr (A), and 72hrs (B) of culture. Phase contrast,
Fluorescin (TUNEL, green), and DAPI(blue) or PI(red) images are shown. Many
TUNEL positive cells were observed in NBSl homozygous(-/-) blastocysts especially
after 72hrs of culture.
Figure 7 Enhanced Transformation of NBSl Heterozygous(+/-) Primary
Fibroblast Cells. NBSl wild-type(+/+) fibroblast cells were unable to form colonies,
and remained as single cells in soft agar(A). On the other hand, NBS 1 heterozygous(+/-)
fibroblast cells formed colonies of various sizes, some over 50 /lm in diameter(B,C,D).
Bar graph(E) represents the size distribution of colonies in soft agar from wild-type(+/+)
and NBSl heterozygous(+/-) primary fibroblast cells.
Figure 8 Histopathological analysis of tumors obtained from NBS
heterozygous(+/-) mice. Three different type of tumors were observed: lung
adenocarcinoma (A x5, B x200), lymphoma from peri-pancreous lymphnode (C x5, D
x200) and hepatocellular carcinoma(HCC) (E x20, F x200). HCC were obtained only
from heterozygous(+/-) male mice, but not from wild-type(+/+) mice. Bar graph
represents tumor incidence among wild-type(+/+) and NBSl heterozygous(+/-) mIce
observed after 1 year. The p values were calculated by Fisher's exact test.
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